Skudexa 75+25 mg granulat til oral opløsning i brev Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

skudexa 75+25 mg granulat til oral opløsning i brev

menarini international operation - dexketoprofentrometamol, tramadolhydrochlorid - granulat til oral opløsning i brev - 75+25 mg

Skudexa 75+25 mg filmovertrukne tabletter Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

skudexa 75+25 mg filmovertrukne tabletter

menarini international operation - dexketoprofentrometamol, tramadolhydrochlorid - filmovertrukne tabletter - 75+25 mg

Trampalgin 37,5 mg+325 mg tabletter Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

trampalgin 37,5 mg+325 mg tabletter

karo pharma as - paracetamol, tramadolhydrochlorid - tabletter - 37,5 mg+325 mg

Xtandi Uni Eropa - Dansk - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Abiraterone Mylan Uni Eropa - Dansk - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abiraterone acetat - prostatiske neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Venlafaxin "Stada" 150 mg depotkapsler, hårde Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

venlafaxin "stada" 150 mg depotkapsler, hårde

stada arzneimittel ag - venlafaxinhydrochlorid - depotkapsler, hårde - 150 mg

Venlafaxin "Stada" 37,5 mg depotkapsler, hårde Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

venlafaxin "stada" 37,5 mg depotkapsler, hårde

stada arzneimittel ag - venlafaxinhydrochlorid - depotkapsler, hårde - 37,5 mg